Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes of cognitive decline for patients 55 years and older. The blood test, which ...

BURLINGTON, N.C., Oct. 23, 2025 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the ...

Labcorp is a science and healthcare company that provides laboratory testing services worldwide. It also functions as a lab facility that conducts research, clinical studies, diagnostic testing, and ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min As the number of Americans at ...

(Reuters) -Labcorp on Tuesday raised its annual profit forecast and beat estimates in the third quarter as the laboratory operator benefited from strong demand for its diagnostic tests. Steady demand ...

Labcorp Holdings said it would soon offer a blood test for diagnosing Alzheimer's disease in primary-care settings. The Burlington, N.C., lab-services company on Thursday said the Elecsys pTau181 test ...

BURLINGTON, N.C. - Labcorp (NYSE:LH), a prominent healthcare diagnostics provider with a market capitalization of $23.5 billion, announced Thursday it will offer the Elecsys pTau181 test nationwide by ...